Published in Thorax on October 11, 2007
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.77
A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother (2009) 1.75
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 1.52
The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49
Technical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.25
Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics (2009) 1.24
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma. Am J Gastroenterol (2013) 0.99
Human B-1 cells take the stage. Ann N Y Acad Sci (2013) 0.97
Immunogenicity of autoantigens. BMC Genomics (2011) 0.97
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer (2010) 0.94
Development of a multiplex autoantibody test for detection of lung cancer. PLoS One (2014) 0.91
Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res (2010) 0.91
Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem Biophys Res Commun (2012) 0.90
Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc (2011) 0.87
Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry. Front Oncol (2012) 0.87
Improving seroreactivity-based detection of glioma. Neoplasia (2009) 0.86
Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts. PLoS One (2014) 0.86
Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep (2013) 0.85
Multiplexed Serum Biomarkers for the Detection of Lung Cancer. EBioMedicine (2016) 0.84
Early lung cancer diagnosis by biosensors. Int J Mol Sci (2013) 0.84
A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer (2010) 0.84
Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodies. Oncoimmunology (2013) 0.84
Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma. J Oncol (2010) 0.84
Serologic laboratory findings in malignancy. Rheum Dis Clin North Am (2011) 0.83
Serum autoantibody measurement for the detection of hepatocellular carcinoma. PLoS One (2014) 0.83
Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. J Transl Med (2015) 0.82
Development and validation of a high throughput system for discovery of antigens for autoantibody detection. PLoS One (2012) 0.82
Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma. Oncol Lett (2014) 0.81
Current readings: blood-based biomarkers for lung cancer. Semin Thorac Cardiovasc Surg (2013) 0.81
Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. J Immunol Methods (2013) 0.81
Molecular recognition of gangliosides and their potential for cancer immunotherapies. Front Immunol (2014) 0.80
Potential biomarkers for lung cancer screening. Transl Lung Cancer Res (2014) 0.80
Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma. BMC Cancer (2013) 0.78
Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer. Oncol Rep (2016) 0.78
Biomarkers of risk to develop lung cancer in the new screening era. Ann Transl Med (2016) 0.78
Nontoxic virus nanofibers improve the detection sensitivity for the anti-p53 antibody, a biomarker in cancer patients. Nano Res (2015) 0.78
Identification of novel autoantibodies for detection of malignant mesothelioma. PLoS One (2013) 0.77
Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study. PLoS One (2015) 0.76
Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection. Cancers (Basel) (2016) 0.76
Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis. Int J Clin Exp Pathol (2015) 0.75
Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment. Front Pharmacol (2016) 0.75
Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med (2016) 0.75
The Pursuit of Noninvasive Diagnosis of Lung Cancer. Semin Respir Crit Care Med (2016) 0.75
A panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Cancer Sci (2017) 0.75
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. Genes Cancer (2016) 0.75
Endogenous antibodies for tumor detection. Sci Rep (2014) 0.75
Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies. Microarrays (Basel) (2015) 0.75
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia. PLoS One (2015) 0.75
Allosteric DNA nanoswitches for controlled release of a molecular cargo triggered by biological inputs. Chem Sci (2016) 0.75
Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer. Oncotarget (2017) 0.75
Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology (2017) 0.75
Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. PLoS One (2017) 0.75
BARD1 serum autoantibodies for the detection of lung cancer. PLoS One (2017) 0.75
In vivo localization of DNA sequences and visualization of large-scale chromatin organization using lac operator/repressor recognition. J Cell Biol (1996) 6.78
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell (1997) 5.47
Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
The use of Xenopus egg extracts to study mitotic spindle assembly and function in vitro. Methods Cell Biol (1999) 4.31
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J (1987) 3.81
Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J (1988) 3.81
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. J Clin Oncol (2000) 3.33
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
Head injuries in three Scottish neurosurgical units. Scottish head injury management study. Br Med J (1979) 2.93
Dynamics of centromeres during metaphase-anaphase transition in fission yeast: Dis1 is implicated in force balance in metaphase bipolar spindle. Mol Biol Cell (1998) 2.79
Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J (1978) 2.65
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer (2001) 2.58
Studies on intercellular LETS glycoprotein matrices. Cell (1978) 2.44
Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology (2002) 2.35
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20
Dibiphytanyl ether lipids in nonthermophilic crenarchaeotes. Appl Environ Microbiol (1998) 2.20
Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: mechanisms of endocytosis. J Gen Microbiol (1984) 2.18
Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol (2007) 2.06
Caudal tramadol for postoperative analgesia in pediatric hypospadias surgery. Br J Anaesth (1997) 2.05
Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. BJOG (2013) 2.00
Fragile X premutation screening in women with premature ovarian failure. Hum Reprod (1998) 1.99
Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer (1989) 1.97
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol (2006) 1.97
Microscopic image analysis for quantitative measurement and feature identification of normal and cancerous colonic mucosa. IEEE Trans Inf Technol Biomed (1998) 1.95
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res (1996) 1.93
Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A (1998) 1.92
RR interval variations in young male diabetics. Br Heart J (1975) 1.91
Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today (1997) 1.91
Serological identification of human tumor antigens. Curr Opin Immunol (1997) 1.91
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res (1990) 1.85
The hydration structure of guanidinium and thiocyanate ions: implications for protein stability in aqueous solution. Proc Natl Acad Sci U S A (2003) 1.83
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess (2004) 1.82
Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer (1998) 1.82
Screening interval breast cancers: mammographic features and prognosis factors. Radiology (1996) 1.82
Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet (1983) 1.78
Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J Gen Virol (1987) 1.78
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants. Hepatology (2000) 1.76
Autonomic mechanisms in the initial heart rate response to standing. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.75
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer (2005) 1.75
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry (2000) 1.71
Patient comfort during cataract surgery with modified topical and peribulbar anesthesia. J Cataract Refract Surg (1997) 1.69
Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A (1998) 1.68
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int J Cancer (2001) 1.65
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin Cancer Res (1999) 1.65
Peripheral and autonomic nerve function in diabetic ketoacidosis. Lancet (1976) 1.62
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer (1995) 1.60
Suppression of infection by famine and its activation by refeeding--a paradox? Perspect Biol Med (1977) 1.60
SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer (1997) 1.60
Early-onset breast cancer--histopathological and prognostic considerations. Br J Cancer (1997) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod (2010) 1.54
Sequence of epicardial repolarisation and configuration of the T wave. Br Heart J (1988) 1.53
Preserved costal cartilage homograft application for the treatment of temporomandibular joint ankylosis. Plast Reconstr Surg (2001) 1.52
FRAXA and FRAXE: the results of a five year survey. J Med Genet (2000) 1.50
Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol (1999) 1.47
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res (2000) 1.47
C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Br J Cancer (1996) 1.44
Reproducibility of three different methods of measuring baroreflex sensitivity in normal subjects. Clin Sci (Lond) (1998) 1.43
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Implications of attendance patterns in Northern Ireland for abdominal aortic aneurysm screening. Eur J Vasc Endovasc Surg (2011) 1.42
Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. Br J Surg (2001) 1.41
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy. Br J Cancer (1995) 1.40
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol (1995) 1.39
Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev (2000) 1.39
Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun (2007) 1.39
Comments on 'A proposal for a generally applicable de minimis dose'. Health Phys (1988) 1.38
Control theory, labeling theory, and the delivery of services for drug abuse to adolescents. Adolescence (1997) 1.38
Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet (1997) 1.37
c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer (1991) 1.37
Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C. J Biol Chem (1999) 1.37
Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol (1995) 1.34
Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33
A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects. Genes Immun (2007) 1.33
Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol (2000) 1.30
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene (1998) 1.30
Systematic comparison of different algorithms for apnoea detection based on electrocardiogram recordings. Med Biol Eng Comput (2002) 1.28
Age-related changes in peripheral pulse timing characteristics at the ears, fingers and toes. J Hum Hypertens (2002) 1.27
Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. Hum Mol Genet (1996) 1.27
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Res Treat (1994) 1.27
Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. Aust N Z J Surg (1996) 1.26
INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Clin Cancer Res (2000) 1.26
Xenopus oocyte maturation does not require new cyclin synthesis. J Cell Biol (1991) 1.26
Effects of aerobic exercise training and yoga on the baroreflex in healthy elderly persons. Eur J Clin Invest (1997) 1.26
Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. Br J Anaesth (2000) 1.25
Expression of cancer testis genes in human brain tumors. Clin Cancer Res (2000) 1.25
Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction. Lancet (1975) 1.25
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer (1994) 1.25
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25